Sharps Compliance Corp (SMED) Posts Q3 Loss of 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SMED Hot Sheet
Join SI Premium – FREE
Sharps Compliance Corp (NASDAQ: SMED) reported Q3 EPS of ($0.06), $0.05 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $6.34 million.
Customer billings were flat at $5.3 million compared to the prior year period. Strong growth in the Professional, Home Health Care, Environmental and Pharmaceutical segments was partially offset by lower flu shot sales in the Retail segment due to the timing of advance orders in the prior year period.
For earnings history and earnings-related data on Sharps Compliance Corp (SMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
- CrossAmerica Partners (CAPL) Misses Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
